In The News

In Bloomberg Law, Margaux Hall Discusses Legal Risks for Medicare as Drug Pricing Negotiation Deadlines Approach

Practices: Health Care, Drug Pricing & Price Reporting, Managed Care, Health Care Finance & Restructuring, Risk Management, Regulatory Enforcement & Civil Litigation Industries: Healthcare & Life Sciences

In a Bloomberg Law article, health care partner Margaux Hall discussed the legal risks for the Centers for Medicare & Medicaid Services in implementing the drug pricing provisions of the Inflation Reduction Act (IRA) as tight deadlines approach.

Margaux explained that CMS appears to intend to implement various IRA drug pricing provisions through guidance, potentially raising the stakes around the statute’s implementation and related legal risks for all stakeholders.

Cookie Settings